Editor-in-Chief eMediNexus – Dr KK Aggarwal
20th November 2019

Medical Devices should be regulated under a Separate Law eventually and not as a Drug beyond 5 years, Nor as amendment to Drugs Act

Dr KK Aggarwal, Recipient of Padma Shri

The Under Secretary (Drug Regulation),
Ministry of Health and Family Welfare, Government of India,
Room No. 414 A, D Wing, Nirman Bhavan,
New Delhi – 110011
Email drugsdiv-mohfw@gov.in

Subject: Comments on Draft Notification # GSR 797 (E) dated 18th October, 2019

Dear Sir,

The subject Draft Notification # GSR 797 (E) dated 18th October, 2019 has been reviewed by the Heart Care Foundation of India (HCFI). The comments of HCFI on the Notification are as follows:

  1. Medical Devices should be regulated under a Separate Law eventually and not as a Drug beyond 5 years, nor as amendment to Drugs Act...read more
Practice Updates

Dengue in the Americas reaches highest number of cases recorded

Dengue in the Americas has reached the highest number of cases recorded so far, with more than 2.7 million cases, including 22,127 severe cases and 1,206 deaths reported at the end of October 2019, according to a new epidemiological update from the Pan American Health Organization (PAHO)... read more

FDA clears first duodenoscope with disposable elevator piece, reducing the number of parts needing disinfection

The U.S. Food and Drug Administration has cleared for marketing in the U.S. the first duodenoscope with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected (reprocessed) in between uses.... read more

Samoa declares state of emergency after measles deaths

Samoa has declared a state of emergency after several deaths linked to a measles outbreak, closing schools and placing restrictions on public gatherings, the Reuters news agency reported. There have been at least six deaths linked to the outbreak in the South Pacific island nation -- mostly infants under the age of two... read more

ORION-9: 50% LDL Reduction with Inclisiran in FH Patients

A third phase 3 trial with the novel lipid-lowering drug inclisiran, which is given just once every 6 months, has shown impressive results in reducing low-density lipoprotein (LDL) levels, consistent with the previous two studies, but this time in patients with familial hypercholesterolemia (FH).... read more

Isatuximab Combo Ups PFS in Relapsed, Refractory Myeloma

The addition of the anti-CD38 antibody isatuximab to standard of care resulted in a 5-month improvement in progression-free survival (PFS) for patients with relapsed and refractory multiple myeloma, according to results of the ICARIA-MM study.... read more

IDEJ Update

Indian Diabetes Educator Journal (IDEJ), 1st of its kind in India aims to keep the members of diabetes care team abreast with concepts of DSME (Diabetes self-management education) and DSMS (Diabetes self-management support). IDEJ has set a new benchmark in educating the diabetes educators about evolving the concept of DSME- reaching to more than 25000 through Digital and Print Medium..... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
a. Chickenpox
b. Measles
c. Mumps
d. Scarlet fever
Lifestyle Updates
Inspirational Story 1: No regrets about today
Inspirational Story 2: Genghis Khan and his Hawk
"To watch 1500+ such videos, please visit www.medtalks.in"